1 Market Overview
1.1 Product Overview and Scope of Menopause Hormonal Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Menopause Hormonal Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Table
1.3.3 Gel
1.3.4 Spray
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Menopause Hormonal Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Menopause Hormonal Drug Market Size & Forecast
1.5.1 Global Menopause Hormonal Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Menopause Hormonal Drug Sales Quantity (2018-2029)
1.5.3 Global Menopause Hormonal Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Menopause Hormonal Drug Product and Services
2.1.4 Merck Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Menopause Hormonal Drug Product and Services
2.2.4 Novartis Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments/Updates
2.3 Novo Nordisk
2.3.1 Novo Nordisk Details
2.3.2 Novo Nordisk Major Business
2.3.3 Novo Nordisk Menopause Hormonal Drug Product and Services
2.3.4 Novo Nordisk Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Menopause Hormonal Drug Product and Services
2.4.4 Pfizer Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business
2.5.3 Allergan Menopause Hormonal Drug Product and Services
2.5.4 Allergan Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Allergan Recent Developments/Updates
2.6 Emcure Pharmaceuticals
2.6.1 Emcure Pharmaceuticals Details
2.6.2 Emcure Pharmaceuticals Major Business
2.6.3 Emcure Pharmaceuticals Menopause Hormonal Drug Product and Services
2.6.4 Emcure Pharmaceuticals Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Emcure Pharmaceuticals Recent Developments/Updates
2.7 Eli Lilly And Company
2.7.1 Eli Lilly And Company Details
2.7.2 Eli Lilly And Company Major Business
2.7.3 Eli Lilly And Company Menopause Hormonal Drug Product and Services
2.7.4 Eli Lilly And Company Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly And Company Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Menopause Hormonal Drug Product and Services
2.8.4 Bayer Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Recent Developments/Updates
2.9 Theramex
2.9.1 Theramex Details
2.9.2 Theramex Major Business
2.9.3 Theramex Menopause Hormonal Drug Product and Services
2.9.4 Theramex Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Theramex Recent Developments/Updates
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Menopause Hormonal Drug Product and Services
2.10.4 AbbVie Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AbbVie Recent Developments/Updates
3 Competitive Environment: Menopause Hormonal Drug by Manufacturer
3.1 Global Menopause Hormonal Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Menopause Hormonal Drug Revenue by Manufacturer (2018-2023)
3.3 Global Menopause Hormonal Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Menopause Hormonal Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Menopause Hormonal Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Menopause Hormonal Drug Manufacturer Market Share in 2022
3.5 Menopause Hormonal Drug Market: Overall Company Footprint Analysis
3.5.1 Menopause Hormonal Drug Market: Region Footprint
3.5.2 Menopause Hormonal Drug Market: Company Product Type Footprint
3.5.3 Menopause Hormonal Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Menopause Hormonal Drug Market Size by Region
4.1.1 Global Menopause Hormonal Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Menopause Hormonal Drug Consumption Value by Region (2018-2029)
4.1.3 Global Menopause Hormonal Drug Average Price by Region (2018-2029)
4.2 North America Menopause Hormonal Drug Consumption Value (2018-2029)
4.3 Europe Menopause Hormonal Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Menopause Hormonal Drug Consumption Value (2018-2029)
4.5 South America Menopause Hormonal Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Menopause Hormonal Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
5.2 Global Menopause Hormonal Drug Consumption Value by Type (2018-2029)
5.3 Global Menopause Hormonal Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
6.2 Global Menopause Hormonal Drug Consumption Value by Application (2018-2029)
6.3 Global Menopause Hormonal Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
7.2 North America Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
7.3 North America Menopause Hormonal Drug Market Size by Country
7.3.1 North America Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Menopause Hormonal Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
8.2 Europe Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
8.3 Europe Menopause Hormonal Drug Market Size by Country
8.3.1 Europe Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Menopause Hormonal Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Menopause Hormonal Drug Market Size by Region
9.3.1 Asia-Pacific Menopause Hormonal Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Menopause Hormonal Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
10.2 South America Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
10.3 South America Menopause Hormonal Drug Market Size by Country
10.3.1 South America Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Menopause Hormonal Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Menopause Hormonal Drug Market Size by Country
11.3.1 Middle East & Africa Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Menopause Hormonal Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Menopause Hormonal Drug Market Drivers
12.2 Menopause Hormonal Drug Market Restraints
12.3 Menopause Hormonal Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Menopause Hormonal Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Menopause Hormonal Drug
13.3 Menopause Hormonal Drug Production Process
13.4 Menopause Hormonal Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Menopause Hormonal Drug Typical Distributors
14.3 Menopause Hormonal Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
更年期ホルモン剤のグローバル市場2023：テーブル、ジェル、スプレー、その他 |
| 【英語タイトル】Global Menopause Hormonal Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 | |
 | ・商品コード：GIR23JU620 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年6月 ・ページ数：105 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| Global Info Research社の最新の調査によると、更年期ホルモン剤のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 本調査レポートは、世界の更年期ホルモン剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本資料の主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 更年期ホルモン剤の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 更年期ホルモン剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・テーブル、ジェル、スプレー、その他 用途別セグメント ・病院薬局、小売薬局、オンライン薬局 主要な市場プレーヤー ・Merck、Novartis、Novo Nordisk、Pfizer、Allergan、Emcure Pharmaceuticals、Eli Lilly And Company、Bayer、Theramex、AbbVie 地域別セグメントは次の地域・国をカバーします。 ・北米（アメリカ、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、更年期ホルモン剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な更年期ホルモン剤メーカーの企業概要、2019年～2022年までの更年期ホルモン剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な更年期ホルモン剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別更年期ホルモン剤の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの更年期ホルモン剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での更年期ホルモン剤市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および更年期ホルモン剤の産業チェーンを掲載しています。 ・第14、15章では、更年期ホルモン剤の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 更年期ホルモン剤の概要 - 種類別分析（2018年vs2022年vs2029年）：テーブル、ジェル、スプレー、その他 - 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局 - 世界の更年期ホルモン剤市場規模・予測 - 世界の更年期ホルモン剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck、Novartis、Novo Nordisk、Pfizer、Allergan、Emcure Pharmaceuticals、Eli Lilly And Company、Bayer、Theramex、AbbVie ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：テーブル、ジェル、スプレー、その他 ・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局 ・更年期ホルモン剤の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・更年期ホルモン剤のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・更年期ホルモン剤のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・更年期ホルモン剤の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・更年期ホルモン剤の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Menopause Hormonal Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Menopause Hormonal Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Menopause Hormonal Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Menopause Hormonal Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Menopause Hormonal Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Menopause Hormonal Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Menopause Hormonal Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Menopause Hormonal Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Novartis, Novo Nordisk, Pfizer and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Menopause Hormonal Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Table
Gel
Spray
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Bayer
Theramex
AbbVie
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Menopause Hormonal Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Menopause Hormonal Drug, with price, sales, revenue and global market share of Menopause Hormonal Drug from 2018 to 2023.
Chapter 3, the Menopause Hormonal Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Menopause Hormonal Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Menopause Hormonal Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Menopause Hormonal Drug.
Chapter 14 and 15, to describe Menopause Hormonal Drug sales channel, distributors, customers, research findings and conclusion.
❖ レポートの目次 ❖
| ★調査レポート[更年期ホルモン剤のグローバル市場2023：テーブル、ジェル、スプレー、その他] (コード：GIR23JU620)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[更年期ホルモン剤のグローバル市場2023：テーブル、ジェル、スプレー、その他]についてメールでお問い合わせ |
